Precision System Science Co

Precision System Science Co Current Assets

The Current Assets of Precision System Science Co (7707.T) as of Sep 23, 2026 is 3.37 B JPY. In the previous year, Current Assets was 4.61 B JPY — a change of -26.96% (lower).

Current Assets

3.37 BJPY

YoY

-26.96%

Last updated:

Current Assets of Precision System Science Co is 2026 3.37 B JPY. Current Assets of Precision System Science Co was 2025 4.61 B JPY. It decreases by -26.96% lower compared to the previous year.

The Precision System Science Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
4.37 B JPY
Jan 1, 2019
4.70 B JPY
Jan 1, 2020
5.27 B JPY
Jan 1, 2021
8.93 B JPY
Jan 1, 2022
6.99 B JPY
Jan 1, 2023
5.87 B JPY
Jan 1, 2024
4.61 B JPY
Jan 1, 2025
3.37 B JPY
The Precision System Science Co Current Assets history
YEARCurrent AssetsYoY
3.37 BJPY-26.96%
4.61 BJPY-21.49%
5.87 BJPY-16.00%
6.99 BJPY-21.68%
8.93 BJPY+69.23%
5.27 BJPY+12.24%
4.70 BJPY+7.60%
4.37 BJPY-13.28%
5.04 BJPY-0.37%
5.05 BJPY+3.49%
4.88 BJPY-12.70%
5.60 BJPY-5.57%
5.93 BJPY+66.01%
3.57 BJPY+2.73%
3.47 BJPY-18.10%
4.24 BJPY+29.69%
3.27 BJPY+2.12%
3.20 BJPY-19.54%
3.98 BJPY+3.56%
3.84 BJPY+12.46%
3.42 BJPY-9.26%
3.77 BJPY+95.69%
1.93 BJPY+41.03%
1.37 BJPY-21.78%
1.75 BJPY+62.93%
1.07 BJPY
Access this data via the Eulerpool API

Precision System Science Co Stock analysis

What does Precision System Science Co do? Precision System Science Co Ltd is a leading company in the field of medical research and diagnostics, founded in Japan in 1989. The company is headquartered in Chiba, Japan and operates branches in Europe, the USA, and Asia. Its business model is focused on providing a wide range of instruments, devices, and services for research, diagnostics, and therapy in the medical industry. The company designs and produces its own products and also offers customized solutions for customers. It is divided into different divisions, including instruments and devices for molecular biology and diagnostics, cell analysis, microscopy, and sample processing. They offer products such as PCR systems, qPCR systems, automated sample preparation systems, and RNA isolation kits for molecular biology and diagnostics. They also produce cell counting systems, flow cytometers, high-speed imaging systems, multi-well plate readers for cell analysis. In the microscopy division, the company manufactures high-quality fluorescence microscopes and deconvolution microscopes for protein and DNA molecule analysis, disease diagnostics, drug development, etc. In the sample processing division, they produce automated stations used for preparing samples for genomics and proteomics analysis. The company is also engaged in research and development of medical devices and instruments to improve the quality of medical diagnostics and therapy. A successful product example is the qPCR thermocycler MIQE used in the diagnosis and therapy of diseases like cancer. Precision System Science Co Ltd has played a significant role in fighting the COVID-19 pandemic by producing test kits for diagnosis and offering advanced PCR systems for mass testing. They are committed to continuous innovation and improvement of their products and services to meet the changing needs of the medical industry. With their strong presence and dedication to providing state-of-the-art and innovative products and services, they will remain a major player in the global market for medical devices and instruments. Precision System Science Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Precision System Science Co stock

Current Assets of Precision System Science Co is 3.37 B JPY in 2026.

Current Assets of Precision System Science Co changed from 4.61 B JPY to 3.37 B JPY, representing a -26.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Precision System Science Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Precision System Science Co historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Precision System Science Co

All Key Metrics — Precision System Science Co